Ask AI
Bill114th CongressFiled May 5, 2015International Affairs
H.R. 2241

Global Health Innovation Act of 2015

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary passed house amended (Dec 18, 2015)

Global Health Innovation Act of 2015

(Sec. 2) This bill directs the U.S. Agency for International Development (USAID) to report annually for four years to Congress regarding:

  • the extent to which global health innovations include drugs, diagnostics, devices, vaccines, electronic and mobile health technologies, and related behavior change and service delivery innovations;
  • how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases;
  • how goals are set for health product development in relation to USAID's health-related goals;
  • how USAID is leveraging U.S. investments to achieve greater impact in health innovation, developing and introducing affordable global health products, and increasing health innovations in the development pipeline;
  • how USAID is coordinating with other federal departments and agencies in support of global health product development; and
  • how USAID is coordinating and aligning global health innovation activities between the Global Development Lab, the Center for Accelerating Innovation and Impact, and the Bureau for Global Health.

What just happenedDec 18, 2015

Received in the Senate and Read twice and referred to the Committee on Foreign Relations.

Who’s behind it

Rep. Sires, Albio [D-NJ-8](D-NJ)Sponsor
21 cosponsors14 D7 R
Read on Congress.gov
21cosponsors2committees14actions16subjects
  1. Dec 18, 2015IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Foreign Relations.

    Foreign Relations Committee
  2. Dec 18, 2015FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  3. Dec 18, 2015FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR 12/16/2015 H9348)

  4. Dec 18, 2015Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR 12/16/2015 H9348)

  5. Dec 18, 2015FloorH30000

    Considered as unfinished business. (consideration: CR H10696)

  6. Dec 16, 2015FloorH37210

    At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Royce objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.

  7. Dec 16, 2015FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 2241.

  8. Dec 16, 2015FloorH30000

    Considered under suspension of the rules. (consideration: CR H9348-9349; text of measure as introduced: CR H9348)

  9. Dec 16, 2015FloorH30300

    Mr. Royce moved to suspend the rules and pass the bill, as amended.

  10. Nov 5, 2015Committee

    Ordered to be Reported (Amended) by Unanimous Consent.

    Foreign Affairs Committee
  11. Nov 5, 2015Committee

    Committee Consideration and Mark-up Session Held.

    Foreign Affairs Committee
  12. May 5, 2015IntroReferralH11100

    Referred to the House Committee on Foreign Affairs.

    Foreign Affairs Committee
  13. May 5, 2015IntroReferralIntro-H

    Introduced in House

  14. May 5, 2015IntroReferral1000

    Introduced in House

Passed House amendedDec 18, 201536

Global Health Innovation Act of 2015

(Sec. 2) This bill directs the U.S. Agency for International Development (USAID) to report annually for four years to Congress regarding:

  • the extent to which global health innovations include drugs, diagnostics, devices, vaccines, electronic and mobile health technologies, and related behavior change and service delivery innovations;
  • how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases;
  • how goals are set for health product development in relation to USAID's health-related goals;
  • how USAID is leveraging U.S. investments to achieve greater impact in health innovation, developing and introducing affordable global health products, and increasing health innovations in the development pipeline;
  • how USAID is coordinating with other federal departments and agencies in support of global health product development; and
  • how USAID is coordinating and aligning global health innovation activities between the Global Development Lab, the Center for Accelerating Innovation and Impact, and the Bureau for Global Health.
Introduced in HouseMay 5, 2015

Global Health Innovation Act of 2015

This bill directs the Administrator of the U.S. Agency for International Development (USAID) to report annually to Congress on the development and use of global health innovations in USAID programs, projects, and activities.

Global Health Innovation Act of 2015 — Informed